Level Bio AB (publ)

DB:4MB Stock Report

Market Cap: €1.6m

Level Bio Management

Management criteria checks 1/4

We currently do not have sufficient information about the CEO.

Key information

Joakim Granemo

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenure2.9yrs
CEO ownershipn/a
Management average tenureno data
Board average tenure5.1yrs

Recent management updates

Recent updates

CEO Compensation Analysis

How has Joakim Granemo's remuneration changed compared to Level Bio's earnings?
DateTotal CompensationSalaryCompany Earnings
Mar 31 2026n/an/a

-SEK 3m

Dec 31 2025n/an/a

-SEK 4m

Sep 30 2025n/an/a

-SEK 4m

Jun 30 2025n/an/a

-SEK 5m

Mar 31 2025n/an/a

-SEK 6m

Dec 31 2024n/an/a

-SEK 8m

Sep 30 2024n/an/a

-SEK 11m

Jun 30 2024n/an/a

-SEK 12m

Mar 31 2024n/an/a

-SEK 11m

Dec 31 2023SEK 1mSEK 981k

-SEK 9m

Sep 30 2023n/an/a

-SEK 5m

Jun 30 2023n/an/a

-SEK 4m

Mar 31 2023n/an/a

-SEK 4m

Dec 31 2022SEK 866kSEK 768k

-SEK 2m

Compensation vs Market: Insufficient data to establish whether Joakim's total compensation is reasonable compared to companies of similar size in the German market.

Compensation vs Earnings: Joakim's compensation has increased whilst the company is unprofitable.

CEO

Joakim Granemo (40 yo)

2.9yrs
Tenure

Mr. Joakim Granemo is Chief Executive Officer of Level Bio AB (publ) from August 2023 and its Director from October 2022.

Board Members

NamePositionTenureCompensationOwnership
Joakim Granemo
CEO & Director3.8yrsno datano data
Ulrica Karlsson
CFO & Directorno dataSEK 945.00kno data
Helene Olsson
Director of Cybergene ABno dataSEK 605.00kno data
Mikael Kubista
Director2.5yrsSEK 25.00kno data
Mikael Havsjo
Director15.3yrsSEK 50.00kno data
Artur Aira
Chairman8.5yrsSEK 100.00kno data
Tobias Schön
Director3.5yrsSEK 50.00k6.85%
€ 106.8k
Neven Zoric
Director6.5yrsSEK 50.00kno data
Claes Gustafsson
Director of Techtum Lab ABno dataSEK 976.00kno data
5.1yrs
Average Tenure
57yo
Average Age

Experienced Board: 4MB's board of directors are considered experienced (5.1 years average tenure).

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/07/07 01:24
End of Day Share Price 2026/07/07 00:00
Earnings2026/03/31
Annual Earnings2025/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Level Bio AB (publ) is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.